These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11531291)

  • 1. Ovarian epithelial dysplasia in relation to ovulation induction and nulliparity.
    Nieto JJ; Crow J; Sundaresan M; Constantinovici N; Perrett CW; MacLean AB; Hardiman PJ
    Gynecol Oncol; 2001 Aug; 82(2):344-9. PubMed ID: 11531291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer.
    Dauplat J; Chene G; Pomel C; Dauplat MM; Le Bouëdec G; Mishellany F; Lagarde N; Bignon YJ; Jaffeux P; Aublet-Cuvelier B; Dechelotte P; Pouly JL; Penault-Llorca F
    Eur J Cancer; 2009 Nov; 45(17):2977-83. PubMed ID: 19822418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian epithelial dysplasia after ovulation induction: time and dose effects.
    Chene G; Penault-Llorca F; Le Bouëdec G; Mishellany F; Dauplat MM; Jaffeux P; Aublet-Cuvelier B; Pouly JL; Dechelotte P; Dauplat J
    Hum Reprod; 2009 Jan; 24(1):132-8. PubMed ID: 18824470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of ovarian pathology after hysterectomy without oophorectomy.
    Plöckinger B; Kölbl H
    J Am Coll Surg; 1994 Jun; 178(6):581-5. PubMed ID: 8193751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hysterectomy with or without unilateral oophorectomy and risk of ovarian cancer.
    Chiaffarino F; Parazzini F; Decarli A; Franceschi S; Talamini R; Montella M; La Vecchia C
    Gynecol Oncol; 2005 May; 97(2):318-22. PubMed ID: 15863124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations.
    Deligdisch L; Gil J; Kerner H; Wu HS; Beck D; Gershoni-Baruch R
    Cancer; 1999 Oct; 86(8):1544-50. PubMed ID: 10526284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hysterectomy, oophorectomy, and subsequent ovarian cancer risk.
    Parazzini F; Negri E; La Vecchia C; Luchini L; Mezzopane R
    Obstet Gynecol; 1993 Mar; 81(3):363-6. PubMed ID: 8437787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma.
    Seidman JD; Wang BG
    Gynecol Oncol; 2007 Jul; 106(1):201-6. PubMed ID: 17477958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial ovarian cancer and the ability to conceive.
    Whittemore AS; Wu ML; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M; Mohle-Boetani J
    Cancer Res; 1989 Jul; 49(14):4047-52. PubMed ID: 2736545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ovarian epithelial dysplasia: Description of a dysplasia scoring scheme].
    Chene G; Dauplat J; Raoelfils I; Bignon YJ; Cayre A; Jaffeux P; Aublet-Cuvelier B; Pomel C; Penault-Llorca F
    Ann Pathol; 2011 Feb; 31(1):3-10. PubMed ID: 21349382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthropometry and the risk of epithelial ovarian cancer.
    Greer JB; Modugno F; Ness RB; Allen GO
    Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovulation induction treatment and risk of borderline ovarian tumors.
    Cusidó M; Fábregas R; Pere BS; Escayola C; Barri PN
    Gynecol Endocrinol; 2007 Jul; 23(7):373-6. PubMed ID: 17701767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Location of inclusion cysts in mouse ovaries in relation to age, pregnancy, and total ovulation number: implications for ovarian cancer?
    Tan OL; Hurst PR; Fleming JS
    J Pathol; 2005 Mar; 205(4):483-90. PubMed ID: 15685692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian cancer in women with prior hysterectomy.
    Davis R; Unger JB
    J La State Med Soc; 2003; 155(2):113-5. PubMed ID: 12778998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of ovulation and ovarian cancer: a critical review of the literature.
    Mahdavi A; Pejovic T; Nezhat F
    Fertil Steril; 2006 Apr; 85(4):819-26. PubMed ID: 16580355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cancer risk after the use of ovulation-stimulating drugs.
    Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
    Obstet Gynecol; 2004 Jun; 103(6):1194-203. PubMed ID: 15172852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.
    Roland IH; Yang WL; Yang DH; Daly MB; Ozols RF; Hamilton TC; Lynch HT; Godwin AK; Xu XX
    Cancer; 2003 Dec; 98(12):2607-23. PubMed ID: 14669280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ovulation induction and the risk of ovarian tumors].
    Franco C; Coppola S; Prosperi Porta R; Patella A
    Minerva Ginecol; 2000 Apr; 52(4):103-9. PubMed ID: 10900940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic oophorectomy: a morphologic and immunohistochemical study.
    Schlosshauer PW; Cohen CJ; Penault-Llorca F; Miranda CR; Bignon YJ; Dauplat J; Deligdisch L
    Cancer; 2003 Dec; 98(12):2599-606. PubMed ID: 14669279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.